Uridine triphosphate trisodium salt
(Synonyms: 尿苷-5'-三磷酸三钠盐) 目录号 : GC37867A nucleotide and dual P2Y2 and P2Y4 receptor agonist
Cas No.:19817-92-6
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Uridine 5'-triphosphate (UTP) is a nucleotide and dual agonist of purinergic P2Y2 and P2Y4 receptors (EC50s = 55 and 80 nM, respectively, for stimulation of phospholipase C in 1321N1 cells expressing human receptors).1,2 It is selective for P2Y2 and P2Y4 receptors over P2Y6 receptors (EC50 = >10,000 nM).2 UTP stimulates proliferation of PANC-1 cells (EC50 = 13.1 μM), an effect that can be prevented by siRNA against the P2Y2 receptor.1 It induces vasoconstriction in perfused isolated canine epicardial coronary artery in a concentration-dependent manner.3 UTP is formed from uridine monophosphate (UMP) by two sequential phosphorylations and can be converted to cytidine 5'-triphosphate .4 It also reacts with glucose-1-phosphate to form UDP-glucose , a precursor in the biosynthesis of glycogen.5
1.Choi, J.H., Ji, Y.G., and Lee, D.H.Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptorPancreas42(4)680-686(2013) 2.Maruoka, H., Jayasekara, M.P.S., Barrett, M.O., et al.Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y4 receptorJ. Med. Chem.54(12)4018-4033(2011) 3.Matsumoto, T., Nakane, T., and Chiba, S.UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptorsBr. J. Pharmacol.122(8)1625-1632(1997) 4.Berg, J.M., Tymoczko, J.L., and Stryer, L.In de novo synthesis, the pyrimidine ring is assembled from bicarbonate, aspartate, and glutamineBiochemistry(2002) 5.Berg, J.M., Tymoczko, J.L., and Stryer, L.Glycogen is synthesized and degraded by different pathwaysBiochemistry(2002)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.8179 mL | 9.0894 mL | 18.1788 mL |
5 mM | 0.3636 mL | 1.8179 mL | 3.6358 mL |
10 mM | 0.1818 mL | 0.9089 mL | 1.8179 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。